EMA Q&As elaborate on paediatric use marketing authorisations and PIPs
This article was originally published in SRA
Executive Summary
The European Medicines Agency has published two question and answer documents concerning the Paediatric Regulation that deal with applying for paediatric use marketing authorisations (PUMAs) and verifying compliance with paediatric investigation plans (PIPs)1,2.